Adding to this growing body of evidence, a recent hospital-based case-control study investigated the relationship between the Alternative Healthy Eating Index (AHEI) and the likelihood of developing endometriosis [73]
Clinical research with Afamelanotide
The main research question is not just weight loss: Tolerability, diabetes outcomes, cardiometabolic endpoints, and approval timing all matter
Here is a structured overview of evidence-backed options: Medical Treatments Muscle relaxers including cyclobenzaprine, baclofen, and methocarbamol are commonly prescribed for acute flare-ups of back spasms, cervical spasms, and leg cramps
Sustainability 17 (13), 6169 (2025) M
After taking the daily pill for about 15 months, heres what participants experienced: Average weight loss of 13.6% across all participants, even those who werent perfectly consistent 16.6% average loss when the medication was taken consistently More than 3 out of 4 participants lost at least 5% of their body weight About 1 in 3 hit the 20% mark or higher But the benefits went beyond what the scale showed